David Socks

Oculir, Inc. develops medical devices. It develops products such as non-invasive glucose meter to measure glucose from white part of the human eye (the conjunctiva). The company was founded by John Burd and David A. Socks in 2003 and is headquartered in San Diego, CA.

Incline Therapeutics, Inc. develops pharmaceutical products. The firm operates as hospital-focused specialty pharmaceutical company focused on the development of IONSYS (fentanyl iontophoretic transdermal system). The company was founded in 2009 and is headquartered in Seatle, WA.

Mallinckrodt Hospital Products, Inc. operates as a biopharmaceutical company, which develops and commercializes proprietary product candidates used in the hospital setting. The firm offers OFIRMEV (acetaminophen injection), a proprietary intravenous formulation of acetaminophen for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics and the reduction of fever. The company was founded by Theodore R. Schroeder, David A. Socks, and Cam L. Garner on May 26, 2004 and is headquartered in Hazelwood, MO.

Windamere Venture Partners LLC (Windamere Venture Partners) is an independent venture capital firm founded in 1999 by Scott L. Glenn. The firm is headquartered in San Diego.

MiraMedica, Inc. supplies, equipment and diagnostic imaging devices. It also supplies digital imaging devices. The company is located in Los Gatos, CA.

Kaiser Associates, Inc. provides boutique strategy consulting services. The private company is based in Washington. Loren Eric Kaiser has been the CEO of the American company since 1999.

Nexcida Therapeutics, Inc. operates in the field of infectious disease therapeutics. The company was founded by Yigong Ge and is headquartered in Menlo Park, CA.

Outpost Medicine LLC develops therapeutics for the treatment of urologic and gynecologic disorders. The company was founded by David Socks and Tachi Yamada in 2016 and is headquartered in Lexington, MA.

Scout Bio, Inc. operates as a biotechnology company that focuses on the innovation of pet medicine by delivering a pipeline of one-time therapeutics for major chronic pet health conditions. It also specializes in gene therapy, veterinary product development and biotechnology investment. The company was founded by James M. Wilson in 2016 and is headquartered in Philadelphia, PA.

Recida Therapeutics, Inc. engages in the development of novel therapeutics. The company was founded by Yigong Ge, Aditya Kohli, and David A. Socks in 2016 and is headquartered in Menlo Park, CA.

Part of Beckley Psytech Ltd., Eleusis Holdings Ltd. is a life science company based in London, UK. The British company is leading translational research in bold new directions and developing a broad and differentiated portfolio of drug candidates to address unmet needs within and beyond psychiatry. Eleusis is dedicated to transforming psychedelics into medicines, empowering patients, and facilitating access to care. The private company was founded in 2017. The CEO is Shlomi Raz. Eleusis Holdings was acquired by Beckley Psytech Ltd.